Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance

The purpose of this study was to analyze the cost-effectiveness of lamivudine (LMV), telbivudine (LdT), and entecavir (ETV) in treatment of chronic hepatitis B with adefovir dipivoxil (ADV) resistance. Two hundred and fifty-two patients were recruited and screened for resistance to ADV and randomly...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guiliang, Liu, Yan, Qiu, Ping, Zhou, Shu-Feng, Xu, Linfang, Wen, Ping, Wen, Jianbo, Xiao, Xianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459610/
https://www.ncbi.nlm.nih.gov/pubmed/26082614
http://dx.doi.org/10.2147/DDDT.S73150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459610/
https://www.ncbi.nlm.nih.gov/pubmed/26082614
http://dx.doi.org/10.2147/DDDT.S73150

Ejemplares similares